Taylor Saunders-Wood (United Kingdom)
University of Cambridge Department of Pathology
Presenter of 1 Presentation
IN VIVO MODEL FOR PAPILLOMAVIRUS INFECTION AND PREVENTION OF TRANSMISSION AND EFFECTIVE DISINFECTION (ID 1309)
Session Time
10:00 - 17:00
Session Type
Poster Viewing - 20-24 July
Session Name
Featured ePosters
Lecture Time
10:06 - 10:07
Introduction
Papillomavirus transmission studies have typically used cell-free virus prepared in organotypic raft culture, or recombinant pseudo-virus isolated from monolayer 293TT cells then been investigated by quantitating viral gene transcripts after infecting reporter cells. During natural in vivo infection however, virions are shed from the epithelial surface in squames, and the successful transmission/infection results in new lesion formation.
Methods
We established an in vivo model, which mimics natural papillomavirus transmission/infection, and evaluated them quantitatively by utilising RNAscope to identify lesion formation microscopically and visual inspection for lesions macroscopically, in conjunction with in vitro infection of reporter cells using HPV16/18 raft virus and HPV16 pseudo-virus.
Results
Similar to HPV, MmuPV1 virus titre/infectivity can be quantified by RT-qPCR (E1^E4) or RNAscope (E6E7) using HaCaT cells. Virus titre/infectivity can be also quantified as periods of lesion formation in vivo model with a 6-log dynamic range. Up to 10 million virus particles can be produced from the surface layers of a productive lesion and transmitted with an approximate one log drop in infectivity if transmission is mediated indirectly on fomites. Virus in squames is stable following desiccation, with minimal loss of titre on fomites over 12 months. In contrast, cell-free MmuPV1 virion is not stable with loss of titre within 8 weeks. The efficacy of disinfectants was also evaluated using these in vitro/vivo models.
Conclusions
MmuPV1 in vitro and in vivo infection models using natural viruses produced from productively infected lesions are powerful methods to investigate PV transmission and susceptibility of PV for disinfectants, which can be utilised for HPV transmission. These models have demonstrated different viral shedding patterns that can affect virus stability and susceptibility for disinfectants. Importantly, we have utilised these models to demonstrate the utility of OPA in stark contrast to other studies.
Hide
Moderator of 1 Session
Session Type
Basic Science Oral Session
Session Time
07:15 - 08:30
[{"name":"ATOMIC RESOLUTION CRYOEM STRUCTURE OF MOUSE PAPILLOMAVIRUS \u003Csmall\u003E(ID 815)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":815,"presentation":"ATOMIC RESOLUTION CRYOEM STRUCTURE OF MOUSE PAPILLOMAVIRUS \u003Csmall\u003E(ID 815)\u003C\/small\u003E","session":"Oral Session 5: Other Anatomical Sites and Diseases","presenter":"Samantha R. Hartmann (United States of America)","photo":""},"playlist":[{"name":"ATOMIC RESOLUTION CRYOEM STRUCTURE OF MOUSE PAPILLOMAVIRUS","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/815 Samantha Hartmann.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/26\/815 Samantha Hartmann.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/2F458AA1.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/815 Samantha Hartmann.vtt"}]},{"name":"TRANSLATIONAL STUDIES OF PEDIATRIC RESPIRATORY PAPILLOMATOSIS \u003Csmall\u003E(ID 608)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":608,"presentation":"TRANSLATIONAL STUDIES OF PEDIATRIC RESPIRATORY PAPILLOMATOSIS \u003Csmall\u003E(ID 608)\u003C\/small\u003E","session":"Oral Session 5: Other Anatomical Sites and Diseases","presenter":"Susanne Wells (United States of America)","photo":""},"playlist":[{"name":"TRANSLATIONAL STUDIES OF PEDIATRIC RESPIRATORY PAPILLOMATOSIS","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/GMT20200708-125945_Susanne-We_1760x900-0.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/26\/GMT20200708-125945_Susanne-We_1760x900-0.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/D43DF196.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/GMT20200708-125945_Susanne-We_1760x900-0.vtt"}]},{"name":"VIRAL GENOME VARIATION IN VULVAR HPV16- ASSOCIATED HIGH GRADE PRECANCER LESIONS AND INVASIVE CANCERS \u003Csmall\u003E(ID 1357)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1357,"presentation":"VIRAL GENOME VARIATION IN VULVAR HPV16- ASSOCIATED HIGH GRADE PRECANCER LESIONS AND INVASIVE CANCERS \u003Csmall\u003E(ID 1357)\u003C\/small\u003E","session":"Oral Session 5: Other Anatomical Sites and Diseases","presenter":"Laura Asensio Puig (Spain)","photo":""},"playlist":[{"name":"VIRAL GENOME VARIATION IN VULVAR HPV16- ASSOCIATED HIGH GRADE PRECANCER LESIONS AND INVASIVE CANCERS","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/Laura Asensio Puig - IPVC20 - 1357 - VIRAL GENOME VARIATION IN VULVAR HPV16- ASSOCIATED HIGH GRADE PRECANCER LESIONS AND INVASIVE CANCERS.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/26\/Laura Asensio Puig - IPVC20 - 1357 - VIRAL GENOME VARIATION IN VULVAR HPV16- ASSOCIATED HIGH GRADE PRECANCER LESIONS AND INVASIVE CANCERS.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/A44D4F17.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/Laura Asensio Puig - IPVC20 - 1357 - VIRAL GENOME VARIATION IN VULVAR HPV16- ASSOCIATED HIGH GRADE PRECANCER LESIONS AND INVASIVE CANCERS.vtt"}]},{"name":"HPV DISTRIBUTION IN DIFFERENT ANATOMICAL SITES \u003Csmall\u003E(ID 377)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":377,"presentation":"HPV DISTRIBUTION IN DIFFERENT ANATOMICAL SITES \u003Csmall\u003E(ID 377)\u003C\/small\u003E","session":"Oral Session 5: Other Anatomical Sites and Diseases","presenter":"Tarik Gheit (France)","photo":""},"playlist":[{"name":"HPV DISTRIBUTION IN DIFFERENT ANATOMICAL SITES","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/Tarik Gheit IPVC 20 377 HPV DISTRIBUTION IN DIFFERENT ANATOMICAL SITES.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/26\/Tarik Gheit IPVC 20 377 HPV DISTRIBUTION IN DIFFERENT ANATOMICAL SITES.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/E86EA0B7.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/Tarik Gheit IPVC 20 377 HPV DISTRIBUTION IN DIFFERENT ANATOMICAL SITES.vtt"}]},{"name":"BETA- AND GAMMA-HPV INFECTIONS IN ASSOCIATION WITH INCIDENT CUTANEOUS SQUAMOUS CELL CARCINOMA: A PROPSECTIVE COHORT STUDY \u003Csmall\u003E(ID 946)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":946,"presentation":"BETA- AND GAMMA-HPV INFECTIONS IN ASSOCIATION WITH INCIDENT CUTANEOUS SQUAMOUS CELL CARCINOMA: A PROPSECTIVE COHORT STUDY \u003Csmall\u003E(ID 946)\u003C\/small\u003E","session":"Oral Session 5: Other Anatomical Sites and Diseases","presenter":"Dana ROLLISON (United States of America)","photo":""},"playlist":[{"name":"BETA- AND GAMMA-HPV INFECTIONS IN ASSOCIATION WITH INCIDENT CUTANEOUS SQUAMOUS CELL CARCINOMA: A PRO","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/GMT20200615-134614_Dana-E--Ro_1920x1200.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/26\/GMT20200615-134614_Dana-E--Ro_1920x1200.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/26966E62.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/GMT20200615-134614_Dana-E--Ro_1920x1200.vtt"}]}]
{"type":2,"code":"9E32UU0s"}
[session]
[presentation]
[presenter]